Private Equity in Healthcare and the Question Dentistry Cannot Ignore
A viral video from ophthalmologist and comedian Dr. Glaucomflecken recently focused attention on a hospital staffing change in Fresno, California. Community Health System plans to turn its hospitalist services over to Sound Physicians, a national medical group backed by Summit Partners and OptumHealth, part of UnitedHealth Group. Glaucomflecken framed the story as another example of private equity and corporate healthcare moving closer to the bedside. The reaction was immediate because the fear underneath the joke is real. Doctors and dentists increasingly wonder how much control they can surrender to insurers, hospital systems, DSOs, private equity firms, management companies, and other intermediaries before they stop controlling their own profession.
The easy response is to turn private equity into the villain in every story. That may be emotionally satisfying, but it is not accurate enough to be useful. Private equity does not automatically produce bad care, and independent ownership does not automatically produce good care. Large organizations can provide capital, technology, purchasing power, standardized systems, sophisticated analytics, and management expertise that smaller practices may struggle to build. Small independent practices can also be poorly managed, understaffed, financially weak, or resistant to needed change. The more useful question is not who owns the organization. It is who controls the clinical decision, what incentives shape that decision, and what happens to measurable outcomes after the ownership or management structure changes.
That distinction matters in Fresno. The Fresno Bee confirmed that Community Health System is moving its hospitalist services to Sound Physicians beginning September 1, 2026. Community says it conducted a formal selection process after more than a year of quality improvement work and chose Sound for its clinical benchmarking, performance measurement, operational support, and experience with hospital quality. The hospital system also says it hopes many existing hospitalists will remain. At the same time, Sound is actively recruiting physicians and other clinical staff for the Fresno market. The widely circulated claim that 120 hospitalists are being displaced has not been independently confirmed. In other words, the structural change is real, but the outcome is not yet known.
Sound itself is an instructive example of modern healthcare consolidation. Summit Partners invested in the company in 2018 as part of a $2.2 billion acquisition that also involved OptumHealth. Summit describes Sound as a physician led multispecialty medical group serving hospitals across hospital medicine, emergency medicine, anesthesia, critical care, telemedicine, and other services. Its stated goal is to improve quality, patient satisfaction, and financial outcomes across the episode of care. There is nothing inherently wrong with that last objective. Every healthcare organization must remain financially viable. The tension begins when improving financial performance requires decisions that may conflict with patient care or professional judgment.
The research is concerning enough that dentists should pay attention, but it needs to be read carefully. A 2025 Health Affairs study compared hospitals acquired by private equity firms with similar hospitals that were not acquired. After acquisition, 30 day postoperative mortality for several common inpatient surgeries increased by 2.7 percentage points relative to controls. The increase was driven largely by failure to rescue, meaning patients developed complications at roughly similar rates but were less likely to survive them. The effect was concentrated in urgent and unplanned surgery, where staffing, response time, operating room capacity, and experienced clinicians matter most.
A separate 2025 study in Annals of Internal Medicine found another troubling pattern. After private equity acquisition, salary expenditures in emergency departments fell 18.2 percent and intensive care salary expenditures fell 15.9 percent. Average staffing declined at the acquired hospitals while staffing increased at comparison hospitals. During the same period, emergency department mortality increased 13.4 percent relative to controls, transfers to other hospitals increased, and intensive care stays became shorter. The study cannot prove that a particular staffing cut caused a particular death, but the combination of reduced clinical spending, fewer employees, more transfers, and higher emergency department mortality deserves attention.
An earlier JAMA study adds another piece to the picture. Researchers examining more than 660,000 Medicare hospitalizations at private equity acquired hospitals found a 25.4 percent relative increase in hospital acquired adverse events after acquisition compared with matched controls. These included problems such as falls and central line infections. Mortality findings were mixed. In hospital mortality declined slightly, while 30 day mortality did not significantly change. That matters because the evidence does not support the simplistic statement that private equity kills patients. It supports a narrower and more defensible conclusion. Some ownership and cost structures can change staffing, resources, and clinician behavior in ways that may affect patient safety.
That is also why a catastrophic maritime injury case should be understood carefully. A seaman with pneumococcal pneumonia was allegedly misdiagnosed at an urgent care clinic, released instead of hospitalized, and later developed sepsis, gangrene, and devastating amputations. The case was about an employer’s responsibility for the medical provider it selected. It was not a private equity case. Its relevance is broader. Whoever controls the patient’s pathway, staffing, referral network, or access to care can create consequences far beyond the original financial decision.
California has decided that control itself is important enough to regulate. The Medical Board of California makes clear that unlicensed corporations cannot control the practice of medicine. Physicians are supposed to retain authority over diagnosis, treatment, referrals, staffing decisions tied to competency, workload, and other functions that affect clinical care. Management organizations can provide administrative services, but they cannot become the real decision maker while a physician merely provides the legal appearance of ownership.
That principle is no longer theoretical. In 2026, California Attorney General Rob Bonta announced a settlement with Carbon Health involving allegations that a management organization exercised effective control over physician owned clinics through what regulators described as a friendly professional corporation structure. California has also challenged similar control issues in dentistry. The lesson for dentists is straightforward. Ownership on paper and control in reality are not always the same thing. Regulators are increasingly interested in who actually has the power to hire, fire, set workload, direct referrals, shape compensation, and override professional judgment.
The Federal Trade Commission is examining a different risk, consolidation. In its case involving Welsh Carson and U.S. Anesthesia Partners, regulators alleged that a private equity backed roll up strategy systematically acquired anesthesia groups across Texas and created enough market power to demand higher prices. The FTC later finalized restrictions on Welsh Carson’s future involvement in certain anesthesia acquisitions. Buying practices and creating scale are not illegal. The problem begins when consolidation becomes strong enough to reduce meaningful competition or give one organization excessive power over prices and terms.
Dentistry should recognize the pattern because the same basic economics are already visible in DSO consolidation. A platform practice is acquired, additional practices are added, purchasing is centralized, administrative functions are standardized, negotiating leverage grows, and the larger organization may eventually be sold or recapitalized. This can create real efficiencies. It can also create pressure to increase production, reduce labor costs, centralize treatment planning, or standardize decisions that may not fit every patient. The important question for a dentist is not whether the organization is called a DSO, a private equity platform, a partnership, or a management company. The question is what happens when the dentist’s clinical judgment and the organization’s financial target point in opposite directions.
Medicine offers another warning that may be even more important than the research on private equity. Independent physician practice has been collapsing for years. According to the American Medical Association, 60.1 percent of physicians worked in private practice in 2012. By 2024, that figure had fallen to 42.2 percent. Hospital ownership has grown far more than private equity ownership, which is an important reality check. Private equity is not the only force reshaping medicine, and probably not the largest one.
The reasons physicians sell are instructive for dentists. The AMA found that physicians commonly cited inadequate reimbursement, the cost of needed resources, and the administrative burden of dealing with payers and regulation. Private equity did not invent those pressures. It found an opportunity inside them. If private equity disappeared tomorrow but the economics of independent practice remained broken, hospitals, insurers, large groups, and other corporate buyers would still have strong incentives to acquire practices.
That may be the most useful lesson for dentistry. Preserving professional autonomy requires more than criticizing consolidation. Independent dentists must build practices capable of surviving without it. That means sound management, strong margins, disciplined purchasing, good technology, competent leadership, thoughtful succession planning, effective patient communication, and enough operational strength that selling remains a choice rather than an escape. A dentist who owns the practice but cannot manage staffing, overhead, collections, case acceptance, or payer pressure may technically be independent while being economically trapped.
The operatory is where all of this becomes real. Most corporate influence will not arrive as someone explicitly telling a dentist to do unnecessary treatment. It will arrive through schedules, production goals, staffing ratios, compensation formulas, preferred vendors, referral rules, case acceptance targets, and expectations about how many patients should be seen each day. Those systems can improve performance when designed well. They can also quietly reshape clinical behavior. A dentist may still feel fully autonomous while responding every day to incentives created far from the chair.
The right response is neither panic nor nostalgia. Follow the incentives and follow the outcomes. Watch clinician turnover, staffing, workload, compensation, patient complaints, case mix, treatment patterns, referral behavior, adverse events, prices, and long term quality. If a larger organization produces better care, better systems, happier clinicians, and stronger financial performance, that deserves recognition. If financial performance improves while clinical autonomy, staffing, and patient outcomes deteriorate, that deserves scrutiny.
Dentistry still has something medicine has already lost to a significant degree, substantial doctor ownership. Whether that remains an advantage will depend less on slogans about private equity and more on whether dentists can build independent practices strong enough to compete with organizations that have more capital, more data, and more management infrastructure.
When doing what is best for the patient costs the organization more money, who really makes the decision?
Join the Conversation!